On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringesCanada is the fourth jurisdiction to approve mRESVIA ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Moderna said on Friday that Canada’s health regulator has ... including mRESVIA and an experimental COVID-flu combination vaccine, to make up for waning post-pandemic demand for COVID products. RSV, ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Domski had sought a religious exemption out of her belief that the three COVID-19 vaccines in wide use at the time — by ...

November 8, 2024) - Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Metagenomi Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) on behalf of ...

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to ...